2Schetz MRC. Classical and alternative indication for continuousrenal replacement therapy. Kidney Int, 1998,53 ( Suppl 66): 129.
3Tetta C, Mariano F, Ronco C, et al. Relevance of platele-activating factor in inflammation and sepsis: mechnisms and kidney removal inextracorporeal treatment. Am J Kidney Dis, 1997, 30 ( 5Suppl 4 ):S57.
4Ronco C, Bellomo R. Continuous renal replacment therapy: Evolution in techololgy and current nomenclature. Kidney Int. 1998,53 (Suppl66):160.
5Van Bommel EFH. Bouvy ND,So KL, et al. Acute dialytic support for the critically ill: Intermittent hemodialysis versus continuous arte-riovenous hemodiafiltration. Am J Nephrol, 1995,15: 192.
6Cosentino F, Paganini E, Lockrem J, et al. Continuous arteriove-nous hemofiltration in the adult respiratory distress syndrome. Con-trib Nephrol, 1991,93:94.
7Sivak ED,Tita J , Meden G, et al. Effects of furosernide versus iso-lated ultrafiltration on extravascular lung water in oleic acid-induced ulmonary edema. Crit Care Med, 1986,14:48.
8Laggner AN. Druml W Lenz K. Influence of ultrafiltration/hemofil-tration on extravascular lung water. Contrib Nephrol, 1991,93:65.
9Moonks R. Gentilello L. Hypothernia induced by continuous arteri-ovenous hemofiltration as a treatment for adult respiratory distress yndrome: A case report. J Trauma, 1996,40:1026.
